LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $291M | +10.4% |
| Gross profit | $141M | +41.5% |
| Operating income | $95M | +1.8% |
| Net income | $197M | — |
| EPS | $9.32 | — |
| Free cash flow | $131M | −0.5% |